HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
Gibbs-Seymour I, Fontana P, Rack JGM, Ahel I. · 2016
Read HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity. by Gibbs-Seymour I, Fontana P, Rack JGM, Ahel I. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4858568.txt.
Introduction
Ian Gibbs-Seymour and co-authors identified a protein, HPF1, in 2016 that steers a DNA repair worker called PARP-1. When DNA breaks, PARP-1 tags proteins with a chemical chain to rally repair. HPF1 binds PARP-1 firmly and rushes to damage sites with it, even before tagging starts. Tests showed HPF1 pushes tagging onto histones, the DNA spools, and curbs PARP-1 tagging itself.
Cells lacking HPF1 grew sensitive to DNA-harming drugs and to PARP blockers used in cancer care. HPF1 thus sits at a crossroads of the damage response, balancing repair signals. Its level might shape how well PARP blocker drugs work, a lead for tailoring cancer treatment.
Catalog record
| CREATOR | Gibbs-Seymour I, Fontana P, Rack JGM, Ahel I. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity By Ian Gibbs-Seymour, Pietro Fontana, Johannes Gregor Matthias Rack, Ivan Ahel Published in: Molecular Cell DOI: 10.1016/j.molcel.2016.03.008 ABSTRACT Summary We report the identification of histone PARylation factor 1 (HPF1; also known as C4orf27) as a regulator of ADP-ribosylation signaling in the DNA damage response. HPF1/C4orf27 forms a robust protein complex with PARP-1 in cells and is recruited to DNA lesions in a PARP-1-dependent manner, but independently of PARP-1 catalytic ADP-ribosylation activity. Functionally, HPF1 promotes PARP-1-dependent in trans ADP-ribosylation of histones and limits DNA damage-induced hyper-automodification of PARP-1. Human cells lacking HPF1 exhibit sensitivity to DNA damaging agents and PARP inhibition, thereby suggesting an important role for HPF1 in genome maintenance and regulating the efficacy of PARP inhibitors. Collectively, our results demonstrate how a fundamental step in PARP-1-dependent ADP-ribosylation signaling is regulated and suggest that HPF1 functions at the crossroads of histone ADP-ribosylation and PARP-1 automodification. INTRODUCTION The integrity of cellular DNA is constantly challenged by endogenous and exogenous sources of damaging agents that cause genome instability, which is a common hallmark of many different cancer types (Hanahan and Weinberg, 2011). To protect the genome from damage, organisms have evolved a cellular defense mechanism termed the DNA damage response (DDR) (Jackson and Bartek, 2009). The DDR includes a diverse set of signal transduction pathways and effector proteins that act to sense DNA lesions and effectively repair the damage to limit propagation of genomic instability to daughter cells. The complex interplay of proteins within DDR pathways requires fine spatiotemporal regulation, which is in part achieved through posttranslational modifications (PTMs), such as ADP-ribosylation, ubiquitylation, SUMOylation, phosphorylation, and acetylation. Defects in proteins involved in the DDR give rise to a range of pathologies, underlining their importance in human health and disease. ADP-ribosylation is the enzymatic process whereby adenosine diphosphate ribose (ADPr) molecules are added to a protein, regulating various aspects of protein function, including activity or subcellular localization (Barkauskaite et al., 2015). ADP-ribosylation has a role in regulating an increasingly diverse array of cellular processes including the DDR, chromatin structure, transcriptional regulation, and RNA processing. As for many PTMs, ADP-ribosylation has “writers,” “readers,” and “erasers,” that is, proteins which establish, recognize, or remove protein ADP-ribosylation, respectively (Barkauskaite et al., 2015). ADPr may be added as a single unit, mono(ADP-ribosyl)ation, or synthesized into polymeric chains, a process termed poly(ADP-ribosyl)ation. Mono- and poly(ADP-ribosyl)ation are catalyzed by a family of proteins called ADP-ribosyl transferases (ARTDs) or poly(ADP-ribose) polymerases (PARPs), which transfer ADPr subunits from nicotinamide adenine dinucleotide (NAD+) to acceptor residues (Perina et al., 2014). Each PARP has distinct ADP-ribosyl transferase activities, with preferences for different substrates. In contrast to these “writers,” mono(ADP-ribose) can be reversed by macrodomain-containing “eraser” proteins, such as terminal ADP-ribose glycohydrolase (TARG), while poly(ADP-ribose) can be degraded by PAR glycohydrolase (PARG) (Sharifi et al., 2013, Slade et al., 2011). Together, these “writers” and “erasers” of ADP-ribosylation ensure that this PTM is highly dynamic and fully reversible in vivo. The founding member of the PARP family, PARP-1, has been the most widely studied of this class of enzymes. The role of PARP-1 in the DDR has been extensively described, with functions in single- and double-strand DNA break repair pathways and replication-fork-associated protection pathways. PARP-1 is activated upon binding to single- and double-strand DNA breaks via its N-terminal zinc finger domains (Ali et al., 2012, Langelier et al., 2012). Upon activation, PARP-1 extensively poly(ADP-ribosyl)ates itself, together with histones and other chromatin-associated proteins (Pascal and Ellenberger, 2015). Functionally, ADP-ribosylation of PARP-1, and presumably histones, promotes the recruitment of a range of DNA repair proteins with poly(ADP-ribose) “reader” domains that are required for lesion processing and repair. PARP-1 automodification has also been suggested to promote PARP-1 release from DNA and/or convert PARP-1 into a histone-binding protein (Muthurajan et al., 2014). Furthermore, various reports have shown that PARP-1 may be regulated by PTMs beyond its own automodification, such as phosphorylation, acetylation, SUMOylation, and ubiquitylation. However, it is not clear how these PTMs function collectively, suggesting that there might be alternative mechanisms to regulate PARP-1 ADP-ribosylation activity in vivo. The last decade has significantly improved our understanding of the key enzymes involved in ADP-ribosylation signaling and the cellular pathways they function within. However, our understanding of how these enzymes are regulated is still in its infancy. Specifically, our understanding of how PARP-1 catalytic activity is regulated in cells and how PARP-1 substrates are targeted is not well defined. Here, we identify the uncharacterized protein C4orf27 as a PARP-1-interacting factor in the DDR. C4orf27 promotes in trans ADP-ribosylation of histones and in turn limits DNA damage-induced hyper-automodification of PARP-1; hence, we have named the gene product HPF1, for histone PARylation factor 1. We propose that as HPF1 and PARP-1 have closely coevolved, the data presented here could therefore be a conserved mechanism of modulating PARP-1 ADP-ribosylation activity in the eukaryotic lineage. RESULTS C4orf27/HPF1 Is a PARP-1-Interacting Protein Recruited to DNA Lesions Previously, we reported the identification of a poly(ADP-ribose)-binding zinc finger (PBZ) domain (Ahel et al., 2008). The PBZ domain is present in a multitude of proteins in the eukaryotic lineage (excluding yeast), and we demonstrated that it was predominantly found in proteins involved in the DDR, suggesting a close coevolution of this domain together with PARP-mediated ADP-ribosylation signaling in response to DNA lesions (Ahel et al., 2008). Since 2008, more eukaryotic genomes have been sequenced, and we now report the presence of the PBZ domain in a number of eukaryotic proteins involved in a diverse range of cellular processes, which have not previously been linked with ADP-ribosylation signaling (Figure S1A, available online). For example, these include serine/threonine kinases, ubiquitin E2 enzymes, and proteases. Though the potential human homologs of these proteins may have never acquired, or lost, a canonical PBZ domain, it suggests that novel aspects of ADP-ribosylation signaling remain to be elucidated. To probe this further, we sought to investigate one of these factors in more detail. We identified a protein in Drosophila melanogaster harboring a PBZ domain, termed CG1218 (Figure 1A) (Ahel et al., 2008, Isogai et al., 2010). The human homolog of CG1218 is the uncharacterized protein C4orf27. C4orf27 is highly conserved in metazoans but is also found in a small number of protozoan species. In contrast to CG1218 (referred to henceforth as Dm C4orf27), human C4orf27 does not contain an N-terminal PBZ domain, but instead consists largely of one domain of unknown function, DUF2228, which is common to all orthologs, as listed in the Pfam database (Figure 1B) (Finn et al., 2016). Analysis of the primary sequences from a variety of organisms revealed that only in several eukaryotic groups such as insects, sea urchins, and mollusks have C4orf27 orthologs gained a PBZ domain during evolution from the last common ancestor (Figure 1B; data not shown). To assay whether the presence of the PBZ conferred the ability to bind poly(ADP-ribose), purified recombinant C4orf27 proteins were dot-blotted onto nitrocellulose and incubated with 32P-labeled poly(ADP-ribose) (Figure 1C). While human C4orf27 did not bind to poly(ADP-ribose), we observed a strong interaction of Dm C4orf27 with poly(ADP-ribose), consistent with the notion that the PBZ domain is the critical determinant for poly(ADP-ribose) binding in C4orf27 homologs. Given that the PBZ domain